To The Moon

$Palantir Technologies Inc.(PLTR)$ stock have been trading up to 140% since Early May. Investors optimism around the company’s artificial intelligence (AI) efforts have fuel the upside. Palantir's AI initiatives prompted Wedbush analyst to initiate a “Outperform” ratings. Market will be looking for more updates on Palantir's AI business when it announces its second-quarter results after 07 Aug (Monday) after hours. In this article, I will be looking at Palantir earnings both from fundamental data as well as from technical analysis indicators. I would be looking to see if Palantir’s AI business has continued to increase its profitability with the recent multiple contracts win. Palantir Technologies (PLTR) Earnings Data The company is expected to re

Hi, Tigers!Welcome to Daily Discussion! This is the place for you to share your trading ideas and win coins!Click here to join the Topic & Win coins >>[Rewards]We will reward you with 50 Tiger Coins when you share your knowledge about stocks and markets here, depending on quality and originality.(NOTE: Comments posted under this article WILL NOT be counted) 2.You will be given 5 Tiger coins if you tag more than 3 friends in the comment areaMeanwhile, we will be list

A Promising Investment Opportunity in the Pharma Industry $Viatris Inc.(VTRS)$ has emerged as a strong contender in the pharmaceutical industry, with a recent surge in its share price driven by outstanding Q2 FY23 earnings and positive developments in its drug pipeline. The company's financial performance beat market estimates, and its promising multiple sclerosis therapy, GA Depot 40 mg, has been accepted for review by the FDA, adding further excitement for investors. In today's ever-changing financial landscape, investors are constantly on the lookout for opportunities that promise significant growth potential. For those seeking to diversify their portfolios and tap into the thriving pharmaceutical sector, Viatris Inc. (VTRS) presents an excitin